Every breast implant has a capsule — a thin layer of scar tissue your body forms around any foreign object. In most patients, this capsule remains thin and pliable. In 5-10% of patients over 10 years, the capsule thickens and tightens — capsular contracture. Early recognition matters: Baker grade I and II contracture often respond to non-surgical management; Baker III and IV typically require surgical intervention. This guide details what's normal versus concerning, when to contact your surgeon, and what early intervention can do.
Your immune system encapsulates any foreign object in tissue — this is normal biology. After breast augmentation, a thin capsule of collagen and connective tissue forms around each implant over 6-8 weeks. In most patients, this capsule remains thin (1-2 mm), pliable, and undetectable. In some patients, the capsule thickens, contracts, and progressively squeezes the implant — capsular contracture.
The four grades (Baker classification). Grade I: breast feels soft and looks natural. Grade II: breast feels firm but looks normal. Grade III: breast feels firm and shows visible distortion (rounded shape, implant edges visible, height shift). Grade IV: breast feels hard, painful, and shows obvious distortion. Grades I-II are managed conservatively; III-IV typically require surgical revision.
Causes — incompletely understood. Multiple factors contribute: subclinical bacterial biofilm on the implant surface (now considered the leading cause of early contracture), implant rupture and silicone migration into the capsule, hematoma during surgery, radiation exposure, and individual immune response variability. The relative contribution of each factor varies by patient.
Frequency by timeframe. 1-3% in first year, 3-5% by 5 years, 5-10% by 10 years cumulative. Modern textured surfaces and antibiotic protocols have reduced rates compared to historical figures of 15-25%. Submuscular placement shows lower rates than subglandular. Patient and surgical factors compound.
The first 8 weeks post-op produce normal firmness that patients sometimes mistake for contracture. Distinguishing normal from concerning matters.
Normal weeks 1-4. Breasts feel firm, sit high on the chest wall ("riding high"), have a rounded upper appearance. This is the result of swelling, muscle tension (submuscular placement), and the implant not yet fully settled. Not contracture.
Normal weeks 4-8. Implants gradually drop and settle. Firmness decreases. Some asymmetry in settling speed between left and right is normal. Breasts begin to look more natural in shape and position.
Normal weeks 8-12. Most settling complete. Breast feels softer, more natural, with normal compression characteristics. Capsule is forming but should not be tight or distorting.
Concerning signs (consult surgeon). Firmness increasing rather than decreasing after week 8. Breast moving higher rather than settling. New asymmetry developing (one side getting firmer, more rounded). Visible distortion (rounded ball shape, implant edges palpable, breast appearing globe-like). Pain or persistent discomfort beyond normal post-op timeline. Sudden changes in breast appearance or feel.
Definitively abnormal (urgent surgeon contact). Hard breast that doesn't compress at all. Severe pain. Visible deformity. Implant appearing displaced upward or laterally. These typically indicate Baker III-IV contracture requiring surgical assessment.
Capsular contracture follows two distinct timeline patterns with different underlying causes and management implications.
Early contracture (months 3-24). Develops within 2 years of surgery. Most often related to subclinical bacterial biofilm on implant surface — bacteria from skin flora that contaminated the implant during placement, formed a biofilm, and triggered chronic inflammation. Prevention focuses on intra-operative protocols (Keller funnel use, antibiotic irrigation, no-touch technique). Management: aggressive antibiotic therapy may help in some cases; surgical revision typically needed for established contracture.
Late contracture (5+ years). Develops years after initial surgery. Often related to implant aging — silicone gel migration through implant shell, microscopic implant damage, or ongoing low-grade immune response. Less responsive to non-surgical management. Surgical revision (capsulectomy plus implant exchange) typically required.
The middle period (years 2-5). Mixed causes. Some cases are delayed presentations of early biofilm-related contracture; others are early presentations of implant-related late contracture. Treatment approach individualized based on specific findings.
Bilateral vs unilateral patterns. Unilateral contracture (one side only) is more common and usually suggests local cause (biofilm, hematoma, technique). Bilateral simultaneous contracture suggests systemic factors or both implants affected by same cause. Bilateral sequential contracture (one side first, then the other) is typical timeline pattern.
Specific risk multipliers. Subglandular placement (3-5x higher rate than submuscular). Periareolar incision (compared to inframammary). Smooth surface (compared to textured — though textured carries other risks like BIA-ALCL). Radiation therapy. Hematoma during surgery. Implant rupture.
Early-grade contracture (Baker I-II) sometimes responds to non-surgical interventions. The evidence is limited but the interventions carry minimal risk.
Implant displacement massage. For round smooth implants, daily 5-minute sessions of moving the implant within the pocket may help maintain capsule pliability. Surgeon-specific protocol — some recommend, others don't. Generally NOT for textured or shaped implants. Discuss with your specific surgeon before starting.
Vitamin E supplementation. Some surgeons recommend 400-800 IU daily vitamin E for early contracture. Limited evidence, but minimal risk at typical doses. Don't exceed 1000 IU daily.
Leukotriene receptor antagonists. Singulair (montelukast) — typically used for asthma — has shown some evidence for capsular contracture treatment. Off-label use, surgeon-prescribed. Some patients show improvement at 4-12 weeks.
External ultrasound therapy. Some practitioners use therapeutic ultrasound for early contracture. Evidence is limited; some patients report improvement. Low-risk intervention.
Maintaining good general health. Smoking cessation, optimal weight, blood pressure control, diabetes management — all reduce inflammatory load and may help. Anti-inflammatory diet patterns may contribute.
Aggressive infection treatment if any infection signs. Even subtle signs of infection (redness, mild fever, fluctuating breast tenderness) warrant aggressive antibiotic therapy if surgeon agrees. Untreated low-grade infection drives contracture progression.
What doesn't work. Excessive massage (can cause damage), aggressive squeezing (can rupture older implants), vitamin megadosing (no evidence, potential harm), bromelain or proteolytic enzymes (no good evidence).
Established Baker III-IV contracture typically requires surgical intervention. Several techniques exist with different trade-offs.
Open capsulotomy. Surgical release of contracted capsule by making cuts in the capsule. Implant typically retained. Lower complication rate but higher recurrence rate (40-60% within 5 years). Reasonable for first-time mild contracture in lower-risk patients.
Capsulectomy. Complete or partial removal of the contracted capsule. New capsule forms around the implant in fresh tissue. Lower recurrence rate (15-30% within 5 years) but more complex surgery. Standard approach for moderate-severe contracture.
Implant exchange + capsulectomy. Capsule removed plus implant replaced with new implant — often with surface change (smooth to textured, or vice versa) and sometimes brand change. Best long-term outcomes (10-20% recurrence at 5 years). Standard for recurrent contracture or when implants are aged.
En-bloc capsulectomy. Capsule and implant removed as single unit, without disrupting capsule edges. Theoretically reduces silicone exposure to surrounding tissue if rupture present. More complex surgery with higher complication rates. Specific indications include suspected silicone leak or BIA-ALCL concern. Not always appropriate or necessary for routine contracture.
Plane change. Implant moved from subglandular to submuscular plane (or vice versa) during revision. Submuscular plane has lower contracture rates — often appropriate plane change for recurrent contracture in original subglandular patient.
Removal without replacement. Some patients choose explant (implant removal) without replacement. Capsule typically removed simultaneously. Aesthetic outcomes vary; some patients report satisfaction with natural breasts, others note visible deformity requiring further surgery (mastopexy, fat transfer).
Recovery from contracture revision surgery. Typically more involved than primary augmentation. Recovery 3-4 weeks for return to most activities, 6-8 weeks for full activity. Drains often used. Outcomes generally good but patient-dependent.
Specific scenarios warrant prompt surgeon contact.
Post-op weeks 4-12 (most concerning period). Increasing rather than decreasing firmness. New asymmetric appearance. Pain not improving. Sudden change in breast position. Any of these warrants prompt evaluation.
Months 3-12 (early contracture period). New firmness developing in previously soft breast. Visible shape change. Implant feeling palpable when it wasn't before. Pain or discomfort that's persistent rather than intermittent.
Years 1-5 (intermediate period). Gradual changes in breast feel or appearance. New asymmetry between sides. Increasing palpability of implant edges. Functional changes (pain with arm movement, sleep position discomfort).
Years 5+ (late contracture period). Any new firmness or shape change deserves assessment. Implant rupture (silent rupture from gel implants often presents as gradual contracture) is more likely in this period.
Specific timing of contact. Routine concerns (gradual changes): scheduled appointment with surgeon, MRI or ultrasound assessment. Acute concerns (rapid changes, pain, fever): prompt urgent contact. Established Baker III-IV: surgical consultation.
What your surgeon will assess. Physical examination (Baker grading), imaging (ultrasound, MRI) to assess implant integrity and capsule features, comparison with previous photos, history of any inciting events (infection, trauma, illness). Together inform recommendation.
For Turkey medical tourism patients. Initial WhatsApp contact with operating surgeon (12-month direct access is standard). Photographs and description sent for remote assessment. If surgeon recommends in-person evaluation, options include: travel back to Turkey for assessment, local plastic surgeon evaluation in your home country with operative records review, or both. Most early-stage assessments are manageable through photographs and descriptions; surgical revision requires in-person care.
Send a WhatsApp message to Dr. Erdal personally — every patient enquiry is reviewed and answered by Dr. Erdal directly, within 24 hours.